Adherence to doxycycline for uncomplicated genitourinary chlamydia: A prospective observational study
Abstract Objectives Since 2020, the Center for Disease Control and Prevention (CDC) no longer recommends single‐dose azithromycin as first‐line therapy for uncomplicated genitourinary chlamydia, advising instead a 7‐day course of doxycycline. Our study investigates self‐reported adherence to the new...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2024-04-01
|
| Sarja: | Journal of the American College of Emergency Physicians Open |
| Linkit: | https://doi.org/10.1002/emp2.13137 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|